• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Reductions in U.S. foreign aid for HIV programs may result in small cost savings but severe clinical consequences

byEvelyn NguyenandDeepti Shroff Karhade
September 1, 2017
in Chronic Disease, Infectious Disease, Obstetrics, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Reducing U.S. foreign aid could produce severe negative clinical and epidemiological effects while saving only $900 or $600 to $900 per year of life lost in the Republic of South Africa (RSA) and Côte d’Ivoire (CI), respectively.

2. Eventually, any cost savings would be negated by the accruing costs of caring for the increased cases of patients with HIV resulting from downscale strategies.

Evidence Rating Level: 3 (Average)

Study Rundown: The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) has assisted resource-limited countries in HIV prevention efforts and in providing antiretroviral treatment (ART). However, the U.S. government is considering reducing U.S. foreign aid by more than $6.7 billion. This study seeks to estimate the clinical, epidemiological, and financial effects of budget cuts in RSA and CI. Using a mathematical model as well as epidemiological and cost data for RSA and CI, researchers compared various methods of downsizing testing, treatment, and monitoring for HIV. Each method was compared to a current standard benchmark. The target population were HIV-infected individuals ≥15 years old beginning in 2016 and continuing for a total of 10 annual cohorts. Outcome measures included the financial savings of each strategy, how many additional infections and deaths would occur, and the number of added years of life lost. The authors concluded that reducing aid would produce severe negative clinical and epidemiological effects and that any cost savings would eventually be negated by the accruing costs of caring for the increased cases of patients with HIV resulting from downscale strategies.

A strength of the study includes a 10-year projection using a well-published mathematical model and published RSA- and CI-specific estimates of HIV-related costs, ART efficacy, and HIV care.

Limitations of the study include the unknown size and details of the actual budget cuts and the unknown degree to which foreign aid sources outside the U.S. may offset any budget cuts.

Click to read the study, published in the Annals of Internal Medicine

RELATED REPORTS

Dolutegravir associated with improved viral suppression in HIV-positive pregnant patients

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

Relevant Reading: PEPFAR in transition — Implications for HIV care in South Africa

In-Depth [mathematical model]: To study various HIV program downscaling methods, researchers used the Cost-Effectiveness of Preventing AIDS Complications–International (CEPAC-I) model, which simulates the progression and treatment of HIV disease in settings with limited resources. The scale-back strategies studied included reserving ART for only the most ill patients, reducing HIV testing, decreasing retention of patients in care, eliminating viral load (VL) testing, and eliminating second-line therapy for those who fail to respond to first-line ART. Researchers estimate that at 10 years, downscaling methods will raise HIV transmissions and deaths in RSA by 0.5% to 19.4% (630 000) and 0.6% to 39.1% (1.664 million), respectively. In CI, HIV transmissions and deaths could increase by as much as 10.5% (24 000) and 34.6% (93 000), respectively. In comparison to the current standard, nearly all methods result in proportionally higher HIV deaths than savings. Even when using the downscaling method that is most efficient and the least damaging to accommodate a 10% to 20% budget cut, only $900 will be saved in RSA and $600 to $900 in CI per year of life lost.

Image: CC/Wiki

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: human immunodeficiency virus (HIV)
Previous Post

Risk model underestimates the negative cardiovascular effects of living in a disadvantaged neighborhood

Next Post

Sleep disordered breathing linked to impaired cognitive function

RelatedReports

Positive physician experience in the Pediatric AIDS Corps
Chronic Disease

Dolutegravir associated with improved viral suppression in HIV-positive pregnant patients

September 5, 2022
Gardasil vaccine demonstrates immunogenic response at 10-year follow-up
Chronic Disease

Long-acting cabotegravir significantly decreases incidence of HIV compared to daily oral tenofovir

May 18, 2022
Pre-exposure prophylaxis (PrEP) effective in preventing HIV infection in high-risk gay men
Chronic Disease

Liposomal amphotericin B noninferior to standard treatment for cryptococcal meningitis

March 29, 2022
Compliance-linked incentives increase infant immunizations rates in rural India
Chronic Disease

High-dose Hepatitis B revaccination schedule improves serological response among patients with Human Immunodeficiency Virus

August 24, 2021
Next Post
CPAP may not decrease cardiovascular events in sleep apnea

Sleep disordered breathing linked to impaired cognitive function

Patient-reported outcomes differ significantly based on treatment in prostate cancer: The ProtecT trial

Re-analysis of evidence suggests that PSA screening significantly reduces the risk for death from prostate cancer

American Academy of Pediatrics recommends standards for adverse event disclosures

Cardiovascular benefits of intensive systolic blood pressure control may outweigh risks of chronic kidney disease events

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options